Guidance

Live attenuated flu vaccine: patient group direction (PGD) template

PGD template to support the administration of live attenuated flu vaccine (Fluenz Trivalent庐) in accordance with national seasonal flu vaccination programme

From:
UK Health Security Agency
Published
10 July 2024
Last updated
8 August 2025 鈥� See all updates

Applies to England

Documents

MS Word Document, 1.43 MB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

MS Word Document, 155 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

罢丑颈蝉听PGD听template supports the administration of live attenuated influenza vaccine (LAIV) (Fluenz Trivalent庐) as part of the听national seasonal influenza vaccination programme.

LAIV听PGD听version 15.00 is valid from 1 September 2025 to 1 April 2026.

Practitioners must not use this听PGD听template until it has been authorised in Section 2. This is a legal requirement (see听).

罢丑颈蝉听PGD听template should be used with reference to current national guidance, the听Green Book, and听听for the vaccine.

Updates to this page

Published 10 July 2024
Last updated 8 August 2025 show all updates

  1. Added 'Addendum to: Live attenuated influenza vaccine nasal spray suspension (LAIV) Patient Group Direction (PGD)'

  2. Added version 15, see page 4 for change history.

  3. First published.

Sign up for emails or print this page

Related content